TABLE 6.
Unadjusted and adjusted models for 3MS trajectory with hormone therapy (HT) type
| Variable | Model 3A |
Model 3B |
||
|---|---|---|---|---|
| β | Sig. | β | Sig. | |
| Intercept | 92.20 | 0.001 | 101.57 | 0.001 |
| Time | 0.05 | 0.413 | 0.27 | 0.001 |
| Time2 | −0.07 | 0.001 | −0.07 | 0.001 |
| HT type | ||||
| Unopposed | 0.57 | 0.002 | 0.28 | 0.128 |
| Opposed | 0.93 | 0.001 | −0.01 | 0.997 |
| No HT (ref.) | — | — | — | — |
| EEE duration | 0.03 | 0.027 | ||
| Baseline age | −0.29 | 0.001 | ||
| Education | 0.62 | 0.001 | ||
| APOE | ||||
| 1 or more E4 | −0.60 | 0.004 | ||
| No E4 (ref.) | — | — | ||
| Physical activity | ||||
| Light | 1.63 | 0.001 | ||
| Moderate | 1.89 | 0.001 | ||
| Vigorous | 1.93 | 0.001 | ||
| Sedentary (ref.) | — | — | ||
| Self-reported health | ||||
| Excellent | 1.88 | 0.001 | ||
| Good | 1.85 | 0.001 | ||
| Fair | 0.96 | 0.069 | ||
| Poor (ref.) | — | — | ||
3MS, Modified Mini-Mental State examination, APOE, apolipoprotein E, EEE, endogenous estrogen exposure, HT, hormone therapy.